May 27, 2025 · “There is no compelling medical need to use HHGE,” added David Barrett, chief executive officer of ASGCT. “We should not pursue this problematic technology when we have …
Regenerative Medicine Conferences & Events | ARM
Discover ARM’s regenerative medicine conferences, workshops, and webinars that unite global leaders to shape the future of CGT. Click to view events.
What Is Cell Therapy and How Does It Work? | ARM
Some cell therapies work by replacing damaged cells, while others guide the immune system to restore balance. As science moves forward, cell therapy is opening new doors for patients with serious and …
Member Directory - Alliance for Regenerative Medicine
From biotech startups to patient groups, ARM members are organizations that are leading the way in promoting, conducting, or supporting research or product development in regenerative medicine.
A-Gene: ARM’s Gene Therapy CMC Resource | ARM
A-Gene is ARM’s flagship resource on gene therapy CMC, offering case studies, webinars, and guidance on Quality by Design approaches. Click here.
With regulatory decisions expected on nine cell and gene therapy products in the US in 2022, ARM’s work to ensure patient access to transformative therapies has never been more important.
Filters - members.alliancerm.org
Gene Therapy Cell Therapy mRNA Tissue Engineering 2025 Alliance for Regenerative Medicine. All rights reserved.
As the Biotech Act advances, ARM stands ready to work with the Commission, Member States, and the European Parliament to ensure that the Biotech Act delivers tangible benefits for patients and …
Internal Header Background
2025 Alliance for Regenerative Medicine. All rights reserved. Privacy Policy Terms of Service Cookies Settings
FDA lifted clinical hold after Discontinued high-recalibration of dosing and dose arm in Phase revision of immuno- 1/2 trial for Rett modulatory regimen for Syndrome Danon Disease